MR
Marvel Biosciences Corp.
MRVL.V · TSXV
$0.11 -0.00% (-$0.00)
1M -21.43%
Market Cap $6.93M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.07
36.4% downside
Current Price
$0.11
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MRVL.V is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 92.98%
ROA 294.94%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.18x
Int. coverage -6.08x
Debt/Equity N/A
Stability
35 /100
Moderate Beta 0.59x
EPS volatility 41,232.17%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MRVL.V
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joseph Roderick Matheson
Employees
5
Headquarters
Calgary